Literature DB >> 13634266

Pilot evaluation of flexin as a tranquilizing agent in chronic mental disorders.

B WILKENS, S MALITZ, M GLUSMAN, P H HOCH.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS/therapy; MUSCLE RELAXANTS/therapeutic use; TRANQUILIZING AGENTS/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13634266     DOI: 10.1007/bf01563029

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


× No keyword cloud information.
  12 in total

1.  Meprobamate in chronic psychiatric patients.

Authors:  L E HOLLISTER; H ELKINS; E G HILER; R ST PIERRE
Journal:  Ann N Y Acad Sci       Date:  1957-05-09       Impact factor: 5.691

2.  Zoxazolamine (flexin) in rheumatic diseases; preliminary report.

Authors:  R T SMITH; K M KRON; W P PEAK; I F HERMANN
Journal:  J Am Med Assoc       Date:  1956-03-03

3.  Effect of zoxazolamine (flexin) in treatment of spasticity; preliminary report.

Authors:  M RODRIGUEZ-GOMEZ; A VALDES-RODRIGUEZ; A L DREW
Journal:  J Am Med Assoc       Date:  1956-03-03

4.  [Nausea epidemica in the Faroe Islands].

Authors:  R K RASMUSSEN
Journal:  Ugeskr Laeger       Date:  1953-04-23

5.  The pharmacological properties of alpha:beta-dihydroxy-gamma-(2-methylphenoxy)-propane (myanesin).

Authors:  F M Berger; W Bradley
Journal:  Br J Pharmacol Chemother       Date:  1946-12

6.  The mode of action of myanesin.

Authors:  F M Berger
Journal:  Br J Pharmacol Chemother       Date:  1947-12

7.  Site of action of myanesin in the central nervous system.

Authors:  B R KAADA
Journal:  J Neurophysiol       Date:  1950-01       Impact factor: 2.714

8.  Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.

Authors:  J C BORRUS
Journal:  J Am Med Assoc       Date:  1955-04-30

9.  2-Amino-5-chlorobenzoxazole (McN-485, flexin), a long-acting spinal cord depressant.

Authors:  K KAMIJO; G B KOELLE
Journal:  Proc Soc Exp Biol Med       Date:  1955-04

10.  The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.

Authors:  F M BERGER
Journal:  J Pharmacol Exp Ther       Date:  1954-12       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.